Matinas BioPharma
MTNB
$0.16
Share price
-5.42%
Change (1 day)
-56.86%
Change (1 year)
Categories
Operating Margin for Matinas BioPharma (MTNB)
Operating Margin as of June 2024 (TTM): -620.08%
According to Matinas BioPharma's latest financial reports and stock price the company's current Operating Margin is -620.08%. At the end of 2021 the company had an Operating Margin of -74,205.01%.
Operating Margin history for Matinas BioPharma from 2017 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -74,205.01% | 385.37% |
| 2020 | -15,288.38% | -27.43% |
| 2019 | -21,067.38% | 72.25% |
| 2018 | -12,230.94% | 10.94% |
| 2017 | -11,024.61% | |
| 2015 | -5,096.04% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.